Legacy Education (LGCY) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
20 Mar, 2026Company overview and market positioning
Operates six campuses in California, focusing on affordable, accredited post-secondary education in allied healthcare, veterinary, and business fields, with 3,234 students enrolled as of December 31, 2025.
Programs are designed for high ROI, shorter durations, and strong job placement, with a 79% graduation rate and 75% placement rate.
Strategic growth through organic enrollment, new program development, and accretive acquisitions, with a 28% five-year enrollment CAGR.
Leadership team averages over 20 years of industry experience, supporting operational stability and growth.
Financial performance and key metrics
Achieved $75.1M in LTM revenue (42% YoY growth) and $12.4M LTM adjusted EBITDA, maintaining a 17% margin.
Ended Q2 FY26 with $21.1M in cash, $27.8M working capital, and $179M market capitalization.
Student acquisition cost is $1.5K, generating over 15x annual revenue per student ($25.0K).
Quarterly enrollment and starts have shown consistent growth, with a 17% YoY increase in student population.
Academic outcomes and program expansion
82% NCLEX pass rate and 75% average placement rate across campuses as of June 30, 2025.
Top five programs by enrollment represent 64% of total enrollment, emphasizing healthcare and allied health fields.
Continuous program innovation, including new offerings in nursing, imaging, veterinary, and dental fields.
Hybrid and interactive distance learning models implemented, with 30–50% of students enrolled via IDL.
Latest events from Legacy Education
- Q2 revenue up 40.7% and net income up 46%, fueled by enrollment and program expansion.LGCY
Q2 202620 Mar 2026 - Achieved 40% revenue growth and 38% enrollment increase, driven by healthcare-focused programs and acquisitions.LGCY
Investor presentation12 Feb 2026 - Revenue up 35%, net income doubled, and expansion fueled by IPO and $8M acquisition.LGCY
Q1 202514 Jan 2026 - Q2 FY2025 revenue up 29.2% with record enrollment and expanded healthcare offerings.LGCY
Q2 202516 Dec 2025 - Virtual meeting to elect six directors, ratify auditor, and review governance and compensation.LGCY
Proxy Filing2 Dec 2025 - Annual proxy details voting items and confirms standard shareholder rights.LGCY
Proxy Filing2 Dec 2025 - IPO targets $10.28M for expansion, with strong growth but high regulatory risk.LGCY
Registration Filing29 Nov 2025 - IPO seeks $10.28M to fund growth, with strong financials but high regulatory exposure.LGCY
Registration Filing29 Nov 2025 - IPO seeks up to $11.95M for expansion, with strong growth but high regulatory risk.LGCY
Registration Filing29 Nov 2025